Prospects for Improving Brain Function in Individuals with Down Syndrome

2013/07/03 by Alberto C. S. Costa, Jonah J. Scott-McKean · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Down syndrome and intellectual disability research #Genetics and Neurodevelopmental Disorders #Ubiquitin and proteasome pathways

paper · doi:10.1007/s40263-013-0089-3

openalex publication_date 2013/07/03 · crossref created 2013/07/03 · crossref issued 2013/07/04 · crossref published 2013/07/04 · crossref published-online 2013/07/04 · crossref published-print 2013/09/01 · crossref deposited 2024/05/13 · openalex created_date 2025/10/10 · crossref indexed 2026/01/22 · openalex updated_date 2026/07/29

Citations

• On the Promise of Pharmacotherapies Targeted at Cognitive and Neurodegenerative Components of Down Syndrome
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
• Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases
• MRI Volumes of the Hippocampus and Amygdala in Adults With Down’s Syndrome With and Without Dementia
• National estimates and race/ethnic‐specific variation of selected birth defects in the United States, 1999–2001
• Neuroanatomy of Down’s Syndrome: A High-Resolution MRI Study
• Spine distribution along the apical dendrites of the pyramidal neurons in Down's syndrome
• Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.

Cited by

• Down syndrome [wikipedia]